Acorda Therapeutics (ACOR)

Acorda Therapeutics (ACOR) Financial Statements


Acorda Therapeutics Financial Overview

Acorda Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.605; its P/E ratio is -0.16; Acorda Therapeutics is scheduled to report earnings on August 3, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 22.26M$ 31.47M$ 33.51M$ 31.05M$ 22.53M
Gross Profit$ 19.02M$ 39.46M$ 22.51M$ 22.25M$ 16.57M
EBIT$ -11.38M$ 27.40M$ -4.97M$ -12.64M$ -16.70M
EBITDA$ -3.69M$ 35.09M$ 2.82M$ -4.20M$ -8.17M
Net Income Common Stockholders$ -16.82M$ 19.14M$ -13.85M$ -46.68M$ -24.52M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 37.24M$ 44.42M$ 20.70M$ 23.13M$ 31.87M
Total Assets$ 372.52M$ 395.60M$ 393.34M$ 406.31M$ 424.14M
Total Debt$ 177.11M$ 172.92M$ 193.75M$ 191.22M$ 193.34M
Net Debt$ 139.86M$ 128.50M$ 173.06M$ 168.09M$ 161.47M
Total Liabilities$ 297.95M$ 301.97M$ 317.57M$ 318.40M$ 296.59M
Stockholders Equity$ 76.96M$ 93.62M$ 75.77M$ 87.91M$ 127.55M
Cash Flow-
Free Cash Flow$ -7.02M$ 9.19M$ -1.99M$ -14.58M$ -13.68M
Operating Cash Flow$ -7.02M$ 9.07M$ -1.84M$ -14.51M$ -13.64M
Investing Cash Flow-$ 123.00K$ -150.00K$ -70.00K$ -39.00K
Financing Cash Flow--$ 0.00$ 0.00$ 0.00
Currency in USD

Acorda Therapeutics Earnings and Revenue History

Acorda Therapeutics Debt to Assets

Acorda Therapeutics Cash Flow

Acorda Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis